Company intelligence / Profile preview

Quotient Sciences

Nottingham, Nottinghamshire, United Kingdomquotientsciences.com ↗

Ownership: Private
Employees: ~1300
Development stage: Commercial

Overview

Quotient Sciences does not develop its own therapeutics but accelerates drug development for clients using its integrated Translational Pharmaceutics® platform. The company has supported over 500 global drug programs with this approach and has worked on more than 1,500 molecules. It has received multiple industry awards for innovation in CRO/CDMO services.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: small moleculessynthetic peptidesoral drug productsinhaled drug productsparenteral drug productstopical drug productsmodified release formulationsoral peptidesradiolabeled compounds
Industry: Contract Research Organization

Partnerships

Ensysce BiosciencesOxilio

Beyond the preview

Go deeper on Quotient Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quotient Sciences.

Explore the full profile